EUVIMEDEUVIMED entdecken
Editorial

Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications

Mark Olfson

American Journal of Psychiatry · 01.11.2026 · 183 (11) · 819-820

DOI: 10.1176/appi.ajp.20260628 ↗

Kurz gefasst

Editorial in der Zeitschrift American Journal of Psychiatry, erschienen am 01.11.2026. Verfasst von Mark Olfson. Beteiligte Einrichtung: Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

EpidemiologyHallucinogensPsychopharmacologySubstance-Related and Addictive Disorders

Autor:innen und Institutionen

  • Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York.

Zitieren

APA

Olfson, M. (2026). Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications. American Journal of Psychiatry, 183(11), 819-820. https://doi.org/10.1176/appi.ajp.20260628

Vancouver

Olfson M. Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications. American Journal of Psychiatry. 2026;183(11):819-820. doi:10.1176/appi.ajp.20260628

BibTeX
@article{Olfson2026,
  author = {Olfson, Mark},
  title = {Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications},
  journal = {American Journal of Psychiatry},
  year = {2026},
  volume = {183},
  number = {11},
  pages = {819--820},
  doi = {10.1176/appi.ajp.20260628}
}
Kostenlos starten →